Other Clinical Trial - Tumor Microenvironment Surveillance on Simultaneous

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05903092` - MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer	Phase 2
Completed	`NCT01935336` - Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers	Phase 2
Completed	`NCT00544596` - R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer	Phase 1
Active, not recruiting	`NCT04063163` - A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)	Phase 3
Terminated	`NCT01217411` - RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer	Phase 1
Completed	`NCT00773955` - R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer	Phase 2
Completed	`NCT00528645` - AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer	Phase 2
Recruiting	`NCT05468489` - To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC	Phase 2
Active, not recruiting	`NCT00828139` - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Phase 2
Recruiting	`NCT05896059` - A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC	Phase 2
Recruiting	`NCT04346914` - Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer	Phase 1
Recruiting	`NCT06323265` - A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Withdrawn	`NCT01325753` - Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body	N/A
Completed	`NCT00019006` - Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer	Phase 1
Not yet recruiting	`NCT04933175` - Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer	Phase 2
Recruiting	`NCT02972320` - Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic	Phase 2
Completed	`NCT01331525` - The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer	Phase 2
Completed	`NCT01155258` - Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	Phase 1
Terminated	`NCT00088933` - Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer	Phase 1
Completed	`NCT00020202` - FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer	Phase 2

NCT number	NCT05055999
Study type	Observational
Source	Hunan Province Tumor Hospital
Contact
Status	Completed
Phase
Start date	April 1, 2019
Completion date	September 1, 2021

Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms